Collectively, these data demonstrate that CD133+ SFCs possess an ability to self-renew in vitro and initiate tumor growth in vivo, indicating that the CD133+ SFCs may provide a true representation of LCSCs in the HCC MHCC97 cell line. The gene discussed is PROM1; the disease is hepatocellular carcinoma.